Compliance and persistence with osteoporosis therapies.
Publication
, Journal Article
Silverman, SL; Gold, DT
Published in: Curr Rheumatol Rep
April 2008
The US Food and Drug Administration has approved a diverse group of effective osteoporosis therapies. However, these therapies obviously only work when patients with osteoporosis take them. Data from retrospective observational databases have shown poor compliance and persistence with all osteoporosis drugs, particularly oral bisphosphonate therapy. Patients on weekly therapies are more compliant and persistent than those on daily dosing. Data have also shown decreased fracture risk, decreased health care utilization, and lower costs in compliant and persistent patients.
Duke Scholars
Published In
Curr Rheumatol Rep
DOI
EISSN
1534-6307
Publication Date
April 2008
Volume
10
Issue
2
Start / End Page
118 / 122
Location
United States
Related Subject Headings
- Rheumatic Diseases
- Patient Compliance
- Osteoporosis
- Injections, Intravenous
- Humans
- Drug Administration Schedule
- Diphosphonates
- Bone Density Conservation Agents
- Arthritis & Rheumatology
- Administration, Oral
Citation
APA
Chicago
ICMJE
MLA
NLM
Silverman, S. L., & Gold, D. T. (2008). Compliance and persistence with osteoporosis therapies. Curr Rheumatol Rep, 10(2), 118–122. https://doi.org/10.1007/s11926-008-0021-x
Silverman, Stuart L., and Deborah T. Gold. “Compliance and persistence with osteoporosis therapies.” Curr Rheumatol Rep 10, no. 2 (April 2008): 118–22. https://doi.org/10.1007/s11926-008-0021-x.
Silverman SL, Gold DT. Compliance and persistence with osteoporosis therapies. Curr Rheumatol Rep. 2008 Apr;10(2):118–22.
Silverman, Stuart L., and Deborah T. Gold. “Compliance and persistence with osteoporosis therapies.” Curr Rheumatol Rep, vol. 10, no. 2, Apr. 2008, pp. 118–22. Pubmed, doi:10.1007/s11926-008-0021-x.
Silverman SL, Gold DT. Compliance and persistence with osteoporosis therapies. Curr Rheumatol Rep. 2008 Apr;10(2):118–122.
Published In
Curr Rheumatol Rep
DOI
EISSN
1534-6307
Publication Date
April 2008
Volume
10
Issue
2
Start / End Page
118 / 122
Location
United States
Related Subject Headings
- Rheumatic Diseases
- Patient Compliance
- Osteoporosis
- Injections, Intravenous
- Humans
- Drug Administration Schedule
- Diphosphonates
- Bone Density Conservation Agents
- Arthritis & Rheumatology
- Administration, Oral